A Jaw-Dropping Consequence: Nintedanib's Role in Osteonecrosis of the Jaw

被引:0
|
作者
Rai, Oshin [1 ]
Romero, Kaitlyn N. [1 ]
Shaykh, Natalie [1 ]
Caldas, Ricardo [1 ]
Tripathi, Vanshika [1 ]
Padilla, Rebekah M. [2 ]
Karan, Abhinav [1 ]
Guo, Hui Jun [1 ]
Jacob, Rafik [3 ]
机构
[1] Univ Florida, Coll Med Jacksonville, Internal Med, Jacksonville, FL 32209 USA
[2] Univ Florida, Coll Med Jacksonville, Diagnost Radiol, Jacksonville, FL USA
[3] Univ Florida, Coll Med Jacksonville, Program Adults Intellectual & Dev Disabil, Jacksonville, FL USA
关键词
idiopathic pulmonary fibrosis and its comorbidities; ipf; osteonecrosis of the jaw; medication-related osteonecrosis of the jaw; nintedanib;
D O I
10.7759/cureus.65689
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nintedanib, a tyrosine kinase inhibitor, is a cornerstone in the management of idiopathic pulmonary fibrosis through its anti-fibrotic effects; however, its impact on wound healing is less studied. We present a case of medication-related osteonecrosis of the jaw (MRONJ) following the initiation of nintedanib. The patient's presentation prompted a drug holiday of nintedanib, resulting in a marked improvement in her symptoms. MRONJ is a disease requiring a high index of suspicion, and the number of inciting medications continues to rise. Nintedanib, as an inhibitor of angiogenesis, may have contributed to poor wound healing following dental extraction, subsequently leading to MRONJ.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Role of microbiota and inflammation in osteonecrosis of the jaw
    Vidal Real, Carmen
    Perez Sayans, Mario
    Suarez Penaranda, Jose M.
    Pardo Sanchez, Fernanda
    Gandara Vila, Pilar
    Blanco Carrion, Andres
    Rodriguez Archilla, Alberto
    Garcia Garcia, Abel
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (04): : 4188 - 4196
  • [32] Osteonecrosis of the jaw
    Felsenberg, Dieter
    OSTEOLOGIE, 2012, 21 (02) : 60 - 60
  • [33] Osteonecrosis of the Jaw
    Gruber, R.
    AUSTRIAN JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 2011, 4 (01): : 8 - 12
  • [34] Bisphosphonate-associated osteonecrosis of the jaw: the rheumatologist's role
    Capsoni, Franco
    Longhi, Matteo
    Weinstein, Roberto
    ARTHRITIS RESEARCH & THERAPY, 2006, 8 (05)
  • [35] Medication-related osteonecrosis of the jaw: the radiologist's role
    Millares, R. Aleman
    Armentia, E. Santos
    Estepar, S. Del Campo
    Ferro, M. Novoa
    RADIOLOGIA, 2023, 65 (05): : 473 - 480
  • [36] Bisphosphonate-associated osteonecrosis of the jaw: the rheumatologist's role
    Franco Capsoni
    Matteo Longhi
    Roberto Weinstein
    Arthritis Research & Therapy, 8
  • [37] The Role of Antiangiogenic Therapy in the Development of Osteonecrosis of the Jaw
    Fantasia, John E.
    ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA, 2015, 27 (04) : 547 - +
  • [38] Osteonecrosis of the Jaw and the Role of Bisphosphonates: A Critical Review
    Silverman, Stuart L.
    Landesberg, Regina
    AMERICAN JOURNAL OF MEDICINE, 2009, 122 (02): : 33 - 45
  • [39] Bisphosphonates and osteonecrosis of the jaw
    Grey, Andrew
    Cundy, Tim
    ANNALS OF INTERNAL MEDICINE, 2006, 145 (10) : 791 - 791
  • [40] Bisphosphonates and osteonecrosis of the jaw
    不详
    EJHP PRACTICE, 2009, 15 (06): : 16 - 16